Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: E9AD90
Term | Name | Level | Count |
---|---|---|---|
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 10 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 11 |
GO:0006364 | rRNA processing | 8 | 11 |
GO:0006396 | RNA processing | 6 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016070 | RNA metabolic process | 5 | 11 |
GO:0016072 | rRNA metabolic process | 7 | 11 |
GO:0030490 | maturation of SSU-rRNA | 9 | 2 |
GO:0034470 | ncRNA processing | 7 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0034660 | ncRNA metabolic process | 6 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090304 | nucleic acid metabolic process | 4 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 168 | 172 | PF00656 | 0.712 |
CLV_NRD_NRD_1 | 202 | 204 | PF00675 | 0.727 |
CLV_NRD_NRD_1 | 205 | 207 | PF00675 | 0.682 |
CLV_PCSK_FUR_1 | 203 | 207 | PF00082 | 0.746 |
CLV_PCSK_KEX2_1 | 205 | 207 | PF00082 | 0.692 |
CLV_PCSK_PC1ET2_1 | 205 | 207 | PF00082 | 0.694 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.610 |
DOC_WW_Pin1_4 | 181 | 186 | PF00397 | 0.620 |
LIG_14-3-3_CanoR_1 | 15 | 19 | PF00244 | 0.559 |
LIG_14-3-3_CanoR_1 | 206 | 212 | PF00244 | 0.677 |
LIG_APCC_ABBA_1 | 79 | 84 | PF00400 | 0.417 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.589 |
LIG_FHA_1 | 30 | 36 | PF00498 | 0.514 |
LIG_FHA_2 | 24 | 30 | PF00498 | 0.331 |
LIG_KLC1_Yacidic_2 | 73 | 77 | PF13176 | 0.535 |
LIG_LIR_Gen_1 | 118 | 126 | PF02991 | 0.412 |
LIG_LIR_Gen_1 | 25 | 35 | PF02991 | 0.419 |
LIG_LIR_Gen_1 | 80 | 90 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 118 | 122 | PF02991 | 0.378 |
LIG_LIR_Nem_3 | 215 | 220 | PF02991 | 0.522 |
LIG_LIR_Nem_3 | 25 | 31 | PF02991 | 0.430 |
LIG_LIR_Nem_3 | 80 | 86 | PF02991 | 0.405 |
LIG_Pex14_2 | 83 | 87 | PF04695 | 0.399 |
LIG_SH2_STAT3 | 10 | 13 | PF00017 | 0.624 |
LIG_SH2_STAT5 | 111 | 114 | PF00017 | 0.367 |
LIG_SH2_STAT5 | 125 | 128 | PF00017 | 0.412 |
LIG_SH2_STAT5 | 132 | 135 | PF00017 | 0.479 |
LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.503 |
LIG_SH2_STAT5 | 82 | 85 | PF00017 | 0.425 |
LIG_SH3_2 | 191 | 196 | PF14604 | 0.699 |
LIG_SH3_3 | 182 | 188 | PF00018 | 0.730 |
LIG_SH3_3 | 189 | 195 | PF00018 | 0.740 |
LIG_TRAF2_1 | 99 | 102 | PF00917 | 0.543 |
LIG_TYR_ITIM | 59 | 64 | PF00017 | 0.499 |
LIG_WW_3 | 193 | 197 | PF00397 | 0.731 |
MOD_CDK_SPK_2 | 181 | 186 | PF00069 | 0.581 |
MOD_CK1_1 | 17 | 23 | PF00069 | 0.585 |
MOD_CK1_1 | 210 | 216 | PF00069 | 0.678 |
MOD_CK2_1 | 117 | 123 | PF00069 | 0.433 |
MOD_CK2_1 | 23 | 29 | PF00069 | 0.333 |
MOD_CK2_1 | 96 | 102 | PF00069 | 0.459 |
MOD_GlcNHglycan | 4 | 7 | PF01048 | 0.660 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.595 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.646 |
MOD_GSK3_1 | 206 | 213 | PF00069 | 0.669 |
MOD_N-GLC_1 | 207 | 212 | PF02516 | 0.670 |
MOD_N-GLC_1 | 23 | 28 | PF02516 | 0.330 |
MOD_NEK2_1 | 14 | 19 | PF00069 | 0.629 |
MOD_PIKK_1 | 23 | 29 | PF00454 | 0.557 |
MOD_PK_1 | 207 | 213 | PF00069 | 0.662 |
MOD_PKA_1 | 206 | 212 | PF00069 | 0.626 |
MOD_PKA_2 | 14 | 20 | PF00069 | 0.563 |
MOD_Plk_1 | 117 | 123 | PF00069 | 0.392 |
MOD_Plk_1 | 207 | 213 | PF00069 | 0.662 |
MOD_Plk_1 | 23 | 29 | PF00069 | 0.333 |
MOD_Plk_1 | 96 | 102 | PF00069 | 0.463 |
MOD_Plk_2-3 | 96 | 102 | PF00069 | 0.478 |
MOD_Plk_4 | 102 | 108 | PF00069 | 0.464 |
MOD_ProDKin_1 | 181 | 187 | PF00069 | 0.618 |
TRG_DiLeu_BaEn_4 | 155 | 161 | PF01217 | 0.538 |
TRG_ENDOCYTIC_2 | 61 | 64 | PF00928 | 0.438 |
TRG_ER_diArg_1 | 211 | 214 | PF00400 | 0.494 |
TRG_NLS_MonoCore_2 | 202 | 207 | PF00514 | 0.710 |
TRG_NLS_MonoExtC_3 | 202 | 207 | PF00514 | 0.658 |
TRG_NLS_MonoExtN_4 | 201 | 208 | PF00514 | 0.649 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IL48 | Leptomonas seymouri | 67% | 100% |
A0A0S4JFC4 | Bodo saltans | 34% | 97% |
A0A1X0P5J5 | Trypanosomatidae | 47% | 100% |
A0A3S7X0M3 | Leishmania donovani | 91% | 100% |
A0A422N5E3 | Trypanosoma rangeli | 46% | 100% |
A4HFN6 | Leishmania braziliensis | 76% | 99% |
A4I2R3 | Leishmania infantum | 91% | 100% |
D0A5W6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 100% |
E9AZ14 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 99% |